Mike Montemarano, Associate Editor 04.12.21
KD Pharma Group, an international contract manufacturer for the pharmaceutical and nutraceutical industries, announced recently that it has acquired the manufacturing assets of the former Rohner AG, a chemical manufacturer based in Switzerland. The assets give KD Pharma access to new complementary technologies that will allow the company to further expand its pharmaceutical contract manufacturing (“CDMO”) business. KD Pharma also hired several key personnel from the former Rohner team who will be involved with the new site.
“KD Pharma has all the technology, capacity, and people to become an even larger player in the CDMO market,” Oscar Groet, CEO of the KD Pharma Group, said. “Rohner was known for its unique chemical processes and technological capabilities, enabling it to manufacture difficult, multi-step pharmaceutical intermediates and APIs. This is a natural fit with our strategy to create health solutions and provide value to consumers by utilizing a unique toolbox of technologies.”
The KD Pharma Group has an existing contract manufacturing site in the U.K., as well as a contract softgel manufacturing site in the United States and omega-3 fatty acid manufacturing sites in Norway and Germany.
Mike Montemarano has been the Associate Editor of Nutraceuticals World since February 2020. He can be reached at mmontemarano@rodmanmedia.com.
“KD Pharma has all the technology, capacity, and people to become an even larger player in the CDMO market,” Oscar Groet, CEO of the KD Pharma Group, said. “Rohner was known for its unique chemical processes and technological capabilities, enabling it to manufacture difficult, multi-step pharmaceutical intermediates and APIs. This is a natural fit with our strategy to create health solutions and provide value to consumers by utilizing a unique toolbox of technologies.”
The KD Pharma Group has an existing contract manufacturing site in the U.K., as well as a contract softgel manufacturing site in the United States and omega-3 fatty acid manufacturing sites in Norway and Germany.
Mike Montemarano has been the Associate Editor of Nutraceuticals World since February 2020. He can be reached at mmontemarano@rodmanmedia.com.
